Summary:
Clinical research study to demonstrate the efficacy and safety of an investigational medication to induce clinical remission in adults with active mild-to-moderate ulcerative colitis.
Qualified Participants Must:
• Be between 18 and 80 years of age
•
Have a diagnosis of active mild-to-moderate ulcerative colitis
Qualified Participants May Receive:
Compensation is available for time and travel